Your browser is no longer supported. Please, upgrade your browser.
Cellect Biotechnology Ltd.
Index- P/E- EPS (ttm)-0.85 Insider Own8.03% Shs Outstand3.91M Perf Week-3.49%
Market Cap11.88M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float3.57M Perf Month21.60%
Income- PEG- EPS next Q- Inst Own14.91% Short Float3.06% Perf Quarter-21.24%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio0.05 Perf Half Y22.58%
Book/sh0.69 P/B4.40 EPS next Y- ROA- Target Price- Perf Year-0.33%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range1.65 - 7.15 Perf YTD40.74%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-56.24% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low89.66% ATR0.29
Employees12 Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)54.65 Volatility6.11% 9.44%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.18 Prev Close3.04
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume2.09M Price3.13
Recom- SMA204.67% SMA5013.02% SMA20018.49% Volume136,892 Change2.91%
Sep-25-17Reiterated H.C. Wainwright Buy $12 → $14
May-17-21 08:50AM  
Apr-19-21 12:10PM  
Mar-29-21 09:29AM  
Mar-25-21 07:58AM  
Mar-24-21 05:26PM  
Mar-09-21 11:56AM  
Nov-20-20 08:00AM  
Oct-29-20 11:55AM  
Oct-22-20 08:00AM  
Sep-21-20 08:30AM  
Aug-12-20 08:00AM  
Aug-06-20 08:30AM  
May-21-20 04:15PM  
May-18-20 08:00AM  
May-12-20 10:09AM  
May-11-20 02:13AM  
Apr-27-20 10:19AM  
Apr-03-20 08:00AM  
Apr-02-20 08:00AM  
Mar-05-20 10:05AM  
Mar-04-20 11:20AM  
Feb-09-20 09:38AM  
Jan-08-20 10:05AM  
Jan-07-20 08:57AM  
Dec-23-19 07:00AM  
Nov-19-19 07:00AM  
Nov-11-19 06:29AM  
Nov-07-19 08:00AM  
Aug-13-19 12:28PM  
Aug-12-19 11:35AM  
Jul-08-19 07:00AM  
May-21-19 07:00AM  
May-16-19 07:00AM  
Mar-27-19 08:00AM  
Mar-18-19 04:15PM  
Mar-12-19 08:15AM  
Mar-11-19 09:35AM  
Feb-13-19 05:00PM  
Feb-08-19 12:55AM  
Feb-05-19 07:30AM  
Jan-28-19 07:00AM  
Jan-23-19 07:20AM  
Dec-17-18 07:00AM  
Nov-21-18 08:45AM  
Nov-13-18 07:00AM  
Nov-05-18 07:00AM  
Nov-01-18 07:00AM  
Oct-22-18 08:00AM  
Oct-18-18 07:00AM  
Oct-15-18 07:16AM  
Aug-20-18 07:00AM  
Aug-13-18 07:00AM  
Aug-09-18 04:15PM  
Aug-07-18 07:00AM  
Jul-09-18 07:00AM  
Jul-05-18 07:00AM  
May-17-18 04:59PM  
May-10-18 07:00AM  
Apr-09-18 07:00AM  
Mar-19-18 04:15PM  
Feb-01-18 12:00PM  
Jan-29-18 08:00AM  
Jan-16-18 07:00AM  
Jan-05-18 01:11PM  
Jan-04-18 08:52AM  
Nov-22-17 07:00AM  
Nov-10-17 07:00AM  
Oct-31-17 08:58AM  
Oct-25-17 10:51AM  
Oct-19-17 07:05AM  
Sep-15-17 07:40AM  
Sep-14-17 07:50AM  
Sep-07-17 09:42AM  
Sep-06-17 08:36AM  
Sep-05-17 07:38AM  
Sep-01-17 07:02AM  
Aug-21-17 07:02AM  
Aug-07-17 07:00AM  
Jun-14-17 08:15AM  
Jun-12-17 07:05AM  
Jun-09-17 09:47AM  
May-29-17 07:00AM  
Cellect Biotechnology Ltd., a biotechnology company, engages in developing ApoGraft, a technology platform that functionally selects stem cells to enhance the safety of regenerative medicine and stem cell therapies in Israel. The company develops ApoTainer, a kit for hematopoietic stem cell transplantation procedures. It has collaborations with the denovoMATRIX group of the Technische UniversitAt Dresden to conduct examinations into the tentative synergy between ApoGraft and denovoMAtrix technology for the purpose of evaluating collaborative development of products for regenerative medicine; Cell2in Inc. to conduct scientific evaluations combining ApoGraft with Cell2in's identification technology FreSHtracer, which monitors stem cell quality by utilizing a fluorescent dye to characterize their oxidative stress state; and XNK therapeutics to focus on the development of cell-based therapeutics from NK cells. The company was formerly known as Cellect Biomed Ltd. and changed its name to Cellect Biotechnology Ltd. in July 2016. Cellect Biotechnology Ltd. was incorporated in 1986 and is headquartered in Kfar Saba, Israel.